Tang Capital Management LLC

10% OwnerRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Oct 13, 2023
Net Buying
Open-Market Buys
$279K
Open-Market Sells
$0
Net Open-Market Flow
$279K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 13, 2023Buy(P)84K$0.99$83K4.0M
Oct 13, 2023Buy(P)47K$0.99$47K3.9M
Oct 12, 2023Buy(P)25K$0.98$25K3.8M
Oct 12, 2023Buy(P)53K$0.98$51K3.9M
Oct 11, 2023Buy(P)75K$0.97$73K3.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052788) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RAIN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-23-052788"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rain Oncology Inc.
over the last 90 days and cite the filings.